637 related articles for article (PubMed ID: 26381230)
1. Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis.
Fang X
Int J Neurosci; 2016 Sep; 126(9):771-6. PubMed ID: 26381230
[TBL] [Abstract][Full Text] [Related]
2. Modification of the gut microbiome to combat neurodegeneration.
Sasmita AO
Rev Neurosci; 2019 Nov; 30(8):795-805. PubMed ID: 31095511
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota in ALS: possible role in pathogenesis?
McCombe PA; Henderson RD; Lee A; Lee JD; Woodruff TM; Restuadi R; McRae A; Wray NR; Ngo S; Steyn FJ
Expert Rev Neurother; 2019 Sep; 19(9):785-805. PubMed ID: 31122082
[No Abstract] [Full Text] [Related]
4. [A role of the gastrointestinal tract microbiota in the pathogenesis of Parkinson's disease].
Alifirova VM; Zhukova NG; Zhukova IA; Latypova AV; Titova MA; Mironova YS; Izhboldina OP; Nikitina MA; Petrov VA
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):174-179. PubMed ID: 28635757
[TBL] [Abstract][Full Text] [Related]
5. Brain-gut-microbiota axis in Parkinson's disease.
Mulak A; Bonaz B
World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
[TBL] [Abstract][Full Text] [Related]
6. The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS).
Boddy SL; Giovannelli I; Sassani M; Cooper-Knock J; Snyder MP; Segal E; Elinav E; Barker LA; Shaw PJ; McDermott CJ
BMC Med; 2021 Jan; 19(1):13. PubMed ID: 33468103
[TBL] [Abstract][Full Text] [Related]
7. Impaired tissue barriers as potential therapeutic targets for Parkinson's disease and amyotrophic lateral sclerosis.
Fang X
Metab Brain Dis; 2018 Aug; 33(4):1031-1043. PubMed ID: 29681010
[TBL] [Abstract][Full Text] [Related]
8. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
9. Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms.
Felice VD; Quigley EM; Sullivan AM; O'Keeffe GW; O'Mahony SM
Parkinsonism Relat Disord; 2016 Jun; 27():1-8. PubMed ID: 27013171
[TBL] [Abstract][Full Text] [Related]
10. Gut-Brain Axis Deregulation and Its Possible Contribution to Neurodegenerative Disorders.
Villavicencio-Tejo F; Olesen MA; Navarro L; Calisto N; Iribarren C; García K; Corsini G; Quintanilla RA
Neurotox Res; 2023 Dec; 42(1):4. PubMed ID: 38103074
[TBL] [Abstract][Full Text] [Related]
11. Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study.
Ning J; Huang SY; Chen SD; Zhang YR; Huang YY; Yu JT
J Alzheimers Dis; 2022; 87(1):211-222. PubMed ID: 35275534
[TBL] [Abstract][Full Text] [Related]
12. Potential Role of the Gut Microbiome in ALS: A Systematic Review.
Wright ML; Fournier C; Houser MC; Tansey M; Glass J; Hertzberg VS
Biol Res Nurs; 2018 Oct; 20(5):513-521. PubMed ID: 29925252
[TBL] [Abstract][Full Text] [Related]
13. Linking Smoking, Coffee, Urate, and Parkinson's Disease - A Role for Gut Microbiota?
Scheperjans F; Pekkonen E; Kaakkola S; Auvinen P
J Parkinsons Dis; 2015; 5(2):255-62. PubMed ID: 25882059
[TBL] [Abstract][Full Text] [Related]
14. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
15. The fecal microbiome of ALS patients.
Brenner D; Hiergeist A; Adis C; Mayer B; Gessner A; Ludolph AC; Weishaupt JH
Neurobiol Aging; 2018 Jan; 61():132-137. PubMed ID: 29065369
[TBL] [Abstract][Full Text] [Related]
16. The Microbiome as a Modifier of Neurodegenerative Disease Risk.
Fang P; Kazmi SA; Jameson KG; Hsiao EY
Cell Host Microbe; 2020 Aug; 28(2):201-222. PubMed ID: 32791113
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota, 1013 new pieces in the Parkinson's disease puzzle.
Scheperjans F
Curr Opin Neurol; 2016 Dec; 29(6):773-780. PubMed ID: 27653288
[TBL] [Abstract][Full Text] [Related]
18. Role of the gut microbiota in the development of various neurological diseases.
Castillo-Álvarez F; Marzo-Sola ME
Neurologia (Engl Ed); 2022; 37(6):492-498. PubMed ID: 35779869
[TBL] [Abstract][Full Text] [Related]
19. Role of the gut microbiota in the development of various neurological diseases.
Castillo-Álvarez F; Marzo-Sola ME
Neurologia (Engl Ed); 2022; 37(6):492-498. PubMed ID: 31340904
[TBL] [Abstract][Full Text] [Related]
20. Lessons to Learn from the Gut Microbiota: A Focus on Amyotrophic Lateral Sclerosis.
Calvo AC; Valledor-Martín I; Moreno-Martínez L; Toivonen JM; Osta R
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
